ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Octapharma launches phase 3 superiority study for PANS pharmaceutical-business-review
September 08, 2020Octapharma has launched a phase 3, multicenter superiority study to compare the effectiveness of PANZYGA (immune globulin intravenous, human - ifas) 10% Liquid Preparation versus placebo in patients with pediatric acute-onset neuropsychiatric syndrome.
Pharma Sources Insight January 2025
